Objectives Current evidence on fecal microbiota transplantation for inflammatory bowel
disease is inconclusive. We conducted a systematic review to gather evidence on the …

As a chronic inflammatory disease, ulcerative colitis has significant negative impact on the
quality of life (QoL) of patients. Since the disease affects many aspects of QoL, comprising …

ABSTRACT Background Interleukin (IL)-36 signaling has been shown to be increased in
ulcerative colitis (UC). Spesolimab, a novel humanized monoclonal antibody, targets the IL …

Background There are limited data on population‐wide assessment of cost in Crohn's
disease (CD) and ulcerative colitis (UC). Aim To estimate the societal cost of actively treated …

Background Patients with ulcerative colitis (UC) experience periods of recurring and
episodic clinical signs and symptoms. This study sought to establish the association …

Background Patient‐reported outcomes are important in the assessment of efficacy of
intervention for ulcerative colitis (UC). Aim To compare the impact of interventions for …

Abstract Background and Aims Ulcerative colitis [UC] impacts patients' health-related quality
of life [HRQoL]. We assessed HRQoL and an exploratory patient-level composite endpoint …

Background and aims In the UK, treatments for patients with moderately to severely active
ulcerative colitis who have an inadequate response to conventional therapies comprise four …

Introduction Treatment goals for ulcerative colitis (UC) are evolving from the achievement of
clinical remission to more rigorous goals defined by endoscopic and histologic healing …

Summary Background Recruitment rates for Crohn's disease and ulcerative colitis clinical
trials continue to decrease annually. The inability to reach recruitment targets and complete …